Rheumatoid lung disease with rheumatoid arthritis of left shoulder
ICD-10 M05.112 is a billable code used to indicate a diagnosis of rheumatoid lung disease with rheumatoid arthritis of left shoulder.
Rheumatoid lung disease is a serious complication of rheumatoid arthritis (RA), characterized by interstitial lung disease, pleuritis, or pulmonary nodules. The left shoulder joint is commonly affected in RA, leading to synovitis, joint erosion, and functional impairment. Anatomically, the shoulder consists of the humerus, scapula, and clavicle, with the glenohumeral joint being the primary articulation. In RA, inflammation can lead to pain, stiffness, and decreased range of motion, impacting daily activities. Clinically, patients may present with dyspnea, cough, and chest discomfort alongside shoulder pain and swelling. The interplay between systemic inflammation and localized joint involvement complicates management and requires a multidisciplinary approach.
Detailed imaging reports (X-rays, MRIs) showing joint erosion and functional assessments (e.g., range of motion tests).
Patients requiring joint injections, arthroscopy, or surgical intervention due to severe joint damage.
Documenting the extent of joint damage and functional limitations is crucial for treatment planning.
Assessment of inflammatory markers (e.g., ESR, CRP), disease activity scores, and patient-reported outcomes.
Management of systemic symptoms alongside joint treatment, including DMARD therapy adjustments.
Monitoring for pulmonary complications and their impact on overall disease management.
Functional assessments focusing on mobility, strength, and endurance, along with rehabilitation goals.
Rehabilitation post-surgery or during flare-ups to improve joint function and mobility.
Addressing assistive device needs and home modifications for patient safety.
Used for managing joint effusion in the left shoulder.
Document the joint involved, amount of fluid aspirated, and any therapeutic agents injected.
Orthopedic considerations for joint health and rheumatologic implications for systemic treatment.
Key documentation includes detailed clinical notes on joint involvement, imaging results, pulmonary function tests, and any inflammatory markers. It is essential to document the severity of both the lung disease and joint involvement to support the coding.
